|
62 Companies |
|
89 Products |
|
89 Products |
|
76 Mechanisms of Action |
|
2 Trials |
|
652 News |
|
| «12345678910111213...1314» |
- ||| Trial completion, Enrollment change, Trial primary completion date: Shared Decision Making in Graves Disease - Graves Disease (GD) Choice (clinicaltrials.gov) - Apr 7, 2015
P=N/A, N=93, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed | N=147 --> 93 | Trial primary completion date: Dec 2014 --> Apr 2015
- acetylcysteine solution / Generic mfg.
Trial completion, Enrollment change: Effects of N-acetylcysteine on Low T3 Syndrome (clinicaltrials.gov) - Mar 31, 2015
P4, N=83, Completed, Sponsor: Federal University of Rio Grande do Sul
Recruiting --> Completed | N=147 --> 93 | Trial primary completion date: Dec 2014 --> Apr 2015 Recruiting --> Completed | N=60 --> 83
- methimazole / Generic mfg.
Trial completion, Trial primary completion date: Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient? (clinicaltrials.gov) - Mar 31, 2015
P2, N=44, Completed, Sponsor: Karolinska Institutet
Recruiting --> Completed | N=60 --> 83 Active, not recruiting --> Completed | Trial primary completion date: Jun 2013 --> Mar 2014
- | ofranergene obadenovec (VB-111) / NanoCarrier, VBL Therap
Enrollment closed, Enrollment change, Trial primary completion date, Metastases: Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer (clinicaltrials.gov) - Mar 27, 2015
P2, N=29, Active, not recruiting, Sponsor: Vascular Biogenics Ltd. operating as VBL Therapeutics
Active, not recruiting --> Completed | Trial primary completion date: Jun 2013 --> Mar 2014 Recruiting --> Active, not recruiting | N=50 --> 29 | Trial primary completion date: Jun 2014 --> Oct 2014
- Trial completion: Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism (clinicaltrials.gov) - Mar 18, 2015
P=N/A, N=80, Completed, Sponsor: Birte Nygaard
Recruiting --> Active, not recruiting | N=50 --> 29 | Trial primary completion date: Jun 2014 --> Oct 2014 Active, not recruiting --> Completed
- Trial primary completion date, Surgery: Complications of Endocrine Surgery: Data From the United HealthSystem Consortium (clinicaltrials.gov) - Mar 10, 2015
P=N/A, N=1000, Active, not recruiting, Sponsor: University of Arkansas
Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
- Actemra IV (tocilizumab) / Roche, JW Pharma
Enrollment closed: Tocilizumab Treatment in Graves (clinicaltrials.gov) - Mar 9, 2015
P3, N=32, Active, not recruiting, Sponsor: Hospital Clinico Universitario de Santiago
Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting
- Trial primary completion date: The TRUST Study - Depression Substudy (clinicaltrials.gov) - Feb 26, 2015
P4, N=1500, Recruiting, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Active, not recruiting Trial primary completion date: Mar 2017 --> Nov 2017
- || buparlisib (AN2025) / Novartis, Adlai Nortye
Trial primary completion date, Metastases: A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies (clinicaltrials.gov) - Feb 26, 2015
P1, N=53, Recruiting, Sponsor: Emory University
Trial primary completion date: Mar 2017 --> Nov 2017 Trial primary completion date: Jan 2015 --> Dec 2015
- ||| dovitinib (TKI258) / Novartis, Oncoheroes
Enrollment closed: SIGNATURE: Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib (clinicaltrials.gov) - Feb 24, 2015
P2, N=80, Active, not recruiting, Sponsor: Novartis Pharmaceuticals
Trial primary completion date: Jan 2015 --> Dec 2015 Recruiting --> Active, not recruiting
- Enrollment change: Thyroid and Glucose and Energy Metabolism (clinicaltrials.gov) - Feb 23, 2015
P2, N=18, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting --> Active, not recruiting N=30 --> 18
- Biomarker, Enrollment open, Trial initiation date, Trial primary completion date: Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants (clinicaltrials.gov) - Feb 11, 2015
P=N/A, N=80, Recruiting, Sponsor: Jill Hamilton-Reeves, PhD RD LD
N=30 --> 18 Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Feb 2015 | Trial primary completion date: May 2015 --> Sep 2017
- Enrollment open, Trial initiation date, Trial primary completion date: Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients (clinicaltrials.gov) - Feb 9, 2015
P2, N=15, Recruiting, Sponsor: Erasmus Medical Center
Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Feb 2015 | Trial primary completion date: May 2015 --> Sep 2017 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Oct 2014 | Trial primary completion date: Jul 2015 --> Feb 2016
- ||| Trial completion, Trial primary completion date: Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery (clinicaltrials.gov) - Feb 2, 2015
P=N/A, N=135, Completed, Sponsor: Yonsei University
Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Oct 2014 | Trial primary completion date: Jul 2015 --> Feb 2016 Recruiting --> Completed | Trial primary completion date: Jun 2014 --> Oct 2014
- | Trial completion, Enrollment change, Trial primary completion date: Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections (clinicaltrials.gov) - Jan 28, 2015
P4, N=50, Completed, Sponsor: Yonsei University
Recruiting --> Completed | Trial primary completion date: Jun 2014 --> Oct 2014 Recruiting --> Completed | N=100 --> 50 | Trial primary completion date: Jul 2012 --> Aug 2014
- ||| Trial completion, Enrollment change, Trial primary completion date: A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open Thyroidectomy (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=169, Completed, Sponsor: Yonsei University
Recruiting --> Completed | N=100 --> 50 | Trial primary completion date: Jul 2012 --> Aug 2014 Recruiting --> Completed | N=120 --> 169 | Trial primary completion date: Aug 2012 --> Sep 2011
- ketorolac / Generic mfg.
Trial primary completion date, Surgery: The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery (clinicaltrials.gov) - Jan 22, 2015
P=N/A, N=160, Recruiting, Sponsor: Yeungnam University College of Medicine
Recruiting --> Completed | N=120 --> 169 | Trial primary completion date: Aug 2012 --> Sep 2011 Trial primary completion date: Dec 2014 --> Jul 2015
- crolibulin (EPC2407) / Immune Pharma
Trial primary completion date: A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) (clinicaltrials.gov) - Jan 20, 2015
P1/2, N=70, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Dec 2014 --> Jul 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Remission Induction and Sustenance in Graves' Disease 2 (clinicaltrials.gov) - Jan 15, 2015
P4, N=250, Active, not recruiting, Sponsor: Aalborg Universitetshospital
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Jan 2015 --> Oct 2015
- Trial primary completion date: Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer (clinicaltrials.gov) - Jan 7, 2015
P2/3, N=74, Active, not recruiting, Sponsor: University Health Network, Toronto
Trial primary completion date: Jan 2015 --> Oct 2015 Trial primary completion date: Dec 2011 --> Dec 2016
- Trial primary completion date: Polymorphisms in the Vitamin D System and Health (clinicaltrials.gov) - Jan 5, 2015
P=N/A, N=9700, Active, not recruiting, Sponsor: University of Tromso
Trial primary completion date: Dec 2011 --> Dec 2016 Trial primary completion date: Oct 2013 --> Oct 2015
- dacarbazine / Generic mfg., imatinib / Generic mfg., capecitabine / Generic mfg.
Trial termination, Trial primary completion date, Combination therapy: Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma (clinicaltrials.gov) - Dec 19, 2014
P1/2, N=21, Terminated, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Oct 2013 --> Oct 2015 Completed --> Terminated | Trial primary completion date: Aug 2013 --> Nov 2006; Study closed following Phase I portion, insufficient activity to continue to Phase II.
- Clinical: Oxidative Status in Children With Autoimmune Thyroiditis (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=64, Completed, Sponsor: Assiut University
- Clinical: Hashimoto - a Surgical Disease. Total Thyroidectomy Makes Antibodies Disappear and Ameliorates Symptoms (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=150, Recruiting, Sponsor: Sykehuset Telemark
- MIKA Diclofenac Spray Gel (diclofenac spraygel) / Nogra Pharma
Trial primary completion date: Adjuvant Treatment of Graves (clinicaltrials.gov) - Dec 17, 2014
P4, N=65, Active, not recruiting, Sponsor: Mikael Lantz
Completed --> Terminated | Trial primary completion date: Aug 2013 --> Nov 2006; Study closed following Phase I portion, insufficient activity to continue to Phase II. Trial primary completion date: May 2014 --> May 2015
- Lumigan (bimatoprost) / Senju, AbbVie
Enrollment open, Trial initiation date, Trial primary completion date: Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) (clinicaltrials.gov) - Dec 17, 2014
P4, N=31, Recruiting, Sponsor: Cardiff University
Trial primary completion date: May 2014 --> May 2015 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Nov 2014 | Trial primary completion date: Feb 2015 --> Dec 2015
- Trial completion, Trial primary completion date: The Role of Elastography in the Diagnosis of Thyroid Nodules (clinicaltrials.gov) - Dec 13, 2014
P=N/A, N=188, Completed, Sponsor: Centre Hospitalier Universitaire de N?mes
Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Nov 2014 | Trial primary completion date: Feb 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Aug 2014
- || dovitinib (TKI258) / Novartis, Oncoheroes
Trial primary completion date: SIGNATURE: Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib (clinicaltrials.gov) - Dec 10, 2014
P2, N=70, Recruiting, Sponsor: Novartis Pharmaceuticals
Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Aug 2014 Trial primary completion date: Sep 2017 --> May 2015
- | Trial completion: Effects of THW and rhTSH in Glomerular Filtration Rate During RIT (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=28, Completed, Sponsor: University of Sao Paulo General Hospital
Trial primary completion date: Sep 2017 --> May 2015 Recruiting --> Completed
- Trial completion, Trial primary completion date: Detection of Celiac Disease in Patients With Hypothyroidism (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=500, Completed, Sponsor: University of Vermont
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2014
- ||| Biomarker, Trial completion, Enrollment change, Trial primary completion date: Molecular Markers in Thyroid Cancer (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=847, Completed, Sponsor: OHSU Knight Cancer Institute
Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2014 Recruiting --> Completed | N=2000 --> 847 | Trial primary completion date: Jan 2020 --> Oct 2010
- New P1 trial: A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication (clinicaltrials.gov) - Dec 5, 2014
P1, N=30, Recruiting, Sponsor: Centre Hospitalier Universitaire de Sherbrooke
- | dovitinib (TKI258) / Novartis, Oncoheroes
Trial completion, Trial primary completion date, Metastases: An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer (clinicaltrials.gov) - Dec 5, 2014
P2, N=40, Completed, Sponsor: Yonsei University
Recruiting --> Completed | N=2000 --> 847 | Trial primary completion date: Jan 2020 --> Oct 2010 Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Oct 2014
- | everolimus / Generic mfg.
Trial completion, Trial primary completion date, Metastases: Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer (clinicaltrials.gov) - Dec 5, 2014
P2, N=40, Completed, Sponsor: Yonsei University
Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Jan 2015 --> Oct 2014
- ||| Trial completion, Trial primary completion date, Surgery: A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=96, Completed, Sponsor: University of Alberta
Recruiting --> Completed | Trial primary completion date: Jan 2015 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Sep 2012
- Surgery: The Efficacy and Safety of Thunderbeat in Thyroid Surgery (clinicaltrials.gov) - Dec 1, 2014
P=N/A, N=1, Not yet recruiting, Sponsor: Seoul National University Hospital
- dexamethasone / Generic mfg.
Surgery: Dexamethasone and Wound Healing After Thyroid Surgery (clinicaltrials.gov) - Dec 1, 2014
P=N/A, N=150, Recruiting, Sponsor: Quanhong Zhou
- ketorolac / Generic mfg.
Enrollment change, Surgery: The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=160, Recruiting, Sponsor: Yeungnam University College of Medicine
Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Sep 2012 N=120 --> 160
- Clinical: Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children. (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=300, Not yet recruiting, Sponsor: Children's Hospital Boston
- Zaltrap (ziv-aflibercept IV) / Sanofi
Trial primary completion date, Metastases: Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy (clinicaltrials.gov) - Nov 19, 2014
P2, N=41, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
N=120 --> 160 Trial primary completion date: Jun 2014 --> Mar 2015
- Trial primary completion date: SNTC: Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia (clinicaltrials.gov) - Nov 13, 2014
P=N/A, N=200, Recruiting, Sponsor: Region Skane
Trial primary completion date: Jun 2014 --> Mar 2015 Trial primary completion date: Mar 2014 --> Dec 2016
- Clinical protocol, Enrollment open: Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery (clinicaltrials.gov) - Nov 13, 2014
P1/2, N=50, Recruiting, Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Trial primary completion date: Mar 2014 --> Dec 2016 Not yet recruiting --> Recruiting
- Trial initiation date, Trial primary completion date: HYPOTYGEN: Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. (clinicaltrials.gov) - Nov 7, 2014
P=N/A, N=350, Recruiting, Sponsor: Assistance Publique - H
Not yet recruiting --> Recruiting Initiation date: Sep 2013 --> May 2013 | Trial primary completion date: Sep 2014 --> Mar 2017
- thyroxine / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism (clinicaltrials.gov) - Nov 5, 2014
P4, N=16, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
Initiation date: Sep 2013 --> May 2013 | Trial primary completion date: Sep 2014 --> Mar 2017 N=10 --> 16 | Initiation date: Sep 2014 --> Dec 2014 | Trial primary completion date: Mar 2015 --> Jun 2015
- Trial completion, Trial initiation date: Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function (clinicaltrials.gov) - Nov 5, 2014
P=N/A, N=20, Completed, Sponsor: University of Roma La Sapienza
N=10 --> 16 | Initiation date: Sep 2014 --> Dec 2014 | Trial primary completion date: Mar 2015 --> Jun 2015 Recruiting --> Completed | Initiation date: Jun 2014 --> Oct 2014
- temozolomide / Generic mfg., capecitabine / Generic mfg.
Trial completion, Metastases: Capecitabine and Temozolomide for Neuroendocrine Cancers (clinicaltrials.gov) - Nov 4, 2014
P2, N=38, Completed, Sponsor: Columbia University
Recruiting --> Completed | Initiation date: Jun 2014 --> Oct 2014 Active, not recruiting --> Completed
- Torisel (temsirolimus) / Pfizer
Trial primary completion date: Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer (clinicaltrials.gov) - Nov 3, 2014
P2, N=40, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
- | New P4 trial: MNP-CAR: Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months (clinicaltrials.gov) - Oct 31, 2014
P4, N=476, Recruiting, Sponsor: Nutrition Center of the Philippines
- | sorafenib / Generic mfg.
Enrollment closed, Metastases: Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients (clinicaltrials.gov) - Oct 30, 2014
P2, N=18, Active, not recruiting, Sponsor: Bayer
Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting
- Iclusig (ponatinib) / Takeda
Trial primary completion date: Ponatinib for Advanced Medullary Thyroid Cancer (clinicaltrials.gov) - Oct 28, 2014
P2, N=31, Recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2016 --> Mar 2016